Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.

Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK.

Ann Diagn Pathol. 2008 Feb;12(1):33-40. doi: 10.1016/j.anndiagpath.2007.02.004. Epub 2007 Oct 24.

PMID:
18164413
2.

The phenotypic spectrum of basal-like breast cancers: a critical appraisal.

Fadare O, Tavassoli FA.

Adv Anat Pathol. 2007 Sep;14(5):358-73. Review.

PMID:
17717437
3.

Clinical and pathologic aspects of basal-like breast cancers.

Fadare O, Tavassoli FA.

Nat Clin Pract Oncol. 2008 Mar;5(3):149-59. doi: 10.1038/ncponc1038. Review.

PMID:
18212769
4.

Breast cancer precursors revisited: molecular features and progression pathways.

Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS.

Histopathology. 2010 Aug;57(2):171-92. doi: 10.1111/j.1365-2559.2010.03568.x. Epub 2010 May 24. Review.

PMID:
20500230
5.

Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets.

Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A, Guillet D, Moulin M, Diaz-Latoud C, Vicart P.

FEBS Lett. 2007 Jul 31;581(19):3665-74. Epub 2007 Apr 24. Review.

6.

Basal carcinoma of the breast revisited: an old entity with new interpretations.

Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H.

J Clin Pathol. 2008 May;61(5):553-60. doi: 10.1136/jcp.2008.055475. Epub 2008 Mar 6. Review.

PMID:
18326009
7.

Gene-expression analysis and the basal-like breast cancer subtype.

Finnegan TJ, Carey LA.

Future Oncol. 2007 Feb;3(1):55-63. Review.

PMID:
17280502
8.

Clinicopathological significance of metallothioneins in breast cancer.

Jin R, Huang J, Tan PH, Bay BH.

Pathol Oncol Res. 2004;10(2):74-9. Epub 2004 Jun 9. Review.

9.

Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.

Celis JE, Gromova I, Gromov P, Moreira JM, Cabezón T, Friis E, Rank F.

FEBS Lett. 2006 May 22;580(12):2935-44. Epub 2006 Apr 12. Review.

10.

Molecular and biologic markers of premalignant lesions of human breast.

Krishnamurthy S, Sneige N.

Adv Anat Pathol. 2002 May;9(3):185-97. Review.

PMID:
11981114
11.

[Automated microscopic image analysis and the prognosis of preneoplasms and carcinomas of the mammary gland].

Guski H, Hufnagl P, Freitag A, Winzer KJ.

Gegenbaurs Morphol Jahrb. 1989;135(1):39-53. Review. German.

PMID:
2544475
12.
13.

Expression of the neuroendocrine phenotype in carcinomas of the breast.

Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G.

Semin Diagn Pathol. 2000 May;17(2):127-37. Review.

PMID:
10839613
14.

Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies.

Mannello F, Tonti GA, Papa S.

Breast Cancer Res Treat. 2006 May;97(2):115-29. Epub 2005 Dec 6. Review.

PMID:
16331347
15.

Molecular alterations in metaplastic breast carcinoma.

Cooper CL, Karim RZ, Selinger C, Carmalt H, Lee CS, O'Toole SA.

J Clin Pathol. 2013 Jun;66(6):522-8. doi: 10.1136/jclinpath-2012-201086. Epub 2013 Jan 31. Review.

PMID:
23372178
16.

Metaplastic carcinoma of the breast--a rare breast tumour.

Saxena S, Bansal A, Mohil RS, Bhatnagar D.

Indian J Pathol Microbiol. 2004 Apr;47(2):217-20. Review.

PMID:
16295473
17.

Demystifying basal-like breast carcinomas.

Da Silva L, Clarke C, Lakhani SR.

J Clin Pathol. 2007 Dec;60(12):1328-32. Epub 2007 May 11. Review.

18.

Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies.

Viale G.

Breast. 2007 Dec;16 Suppl 2:S55-8. Epub 2007 Aug 21. Review.

PMID:
17714946
19.
20.

[Metaplastic breast cancer with chondroid differentiation. Report of three cases].

Vandenhaute B, Validire P, Veilleux C, Vielh P, Zafrani B.

Ann Pathol. 1995;15(1):53-8. Review. French.

PMID:
7702669

Supplemental Content

Support Center